diffuse large B-cell lymphoma: Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL; see this term) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common.
| Name | C3_DLBCL |
|---|---|
| Long name | Diffuse large B-cell lymphoma |
| Cause of Death registry | ICD-10: C84/C85/C83, ICD-9: 200, ICD-8: 200 |
| Cancer reg: TOPOGRAPHY codes | C42|C77 |
| Cancer reg: MORPHOLOGY codes | 9680 |
| Conditions required | HLP_C3_DLBCL |
| Level in the ICD-hierarchy | C |
| First defined in version | DF4 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 209 | 101 | 108 |
| Unadjusted prevalence (%) | 0.10 | 0.08 | 0.11 |
| Mean age at first event (years) | 64.81 | 63.80 | 65.75 |
| Case fatality at 5-years (%) | 11.96 | 4.95 | 18.52 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 1.42 | 1.27 | 1.54 |
before Diffuse large B-cell lymphoma
after Diffuse large B-cell lymphoma
Loading survival analyses plot…
Loading survival analyses table…